Inactive Instrument

Other languages Willow Biosciences Inc Canadian Securities Exchange

Equities

CA97111B1076

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Willow Biosciences Narrows 2023 Loss YOY	Apr. 01
Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29
Willow Biosciences Inc. Announces Collaboration with Global Active Pharmaceutical Ingredient Manufacturer to Develop A More Sustainable, Cost-Effective Manufacturing Process for A Large Volume Global Market	Jan. 31
Willow Biosciences Announces Collaboration with Active Pharmaceutical Ingredient Manufacturer to Manufacture More Sustainable, Cost-Effective Manufacturing Route for Their Largest Product Sold Globally	Jan. 31
Willow Biosciences Inc. Announces Collaboration with Enterin, Inc. to Develop Sustainable Interimates and Active Pharmaceutical Ingredients	Jan. 16
Willow Biosciences Highlights Growth Plans for 2024, Provides 2023 Highlights	Jan. 10
Willow Biosciences prevé que 2024 será un gran año -- Market Talk	Jan. 10
Willow Biosciences Reports Q3 Results, Provides Update	Nov. 15
Willow Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Willow Biosciences Inc. and Suanfarma Announce Collaboration on Development of Large Volume Anti-Infective API Through Precision Fermentation	23-10-03
Willow Biosciences Announced Company Insider Led Convertible Debenture Financing	23-09-12
Willow Biosciences Announced Completion of R&D Program on Cost Effective, Sustainably Produced UDCA	23-09-06
Willow Biosciences Inc. Announces Successful Completion of R&D Program on Covid	23-09-06
Willow Biosciences Inc. Announces Filing of Patent Application for Process to Produce Corticosteroids At Significantly Reduced Cost	23-08-30
Willow Biosciences Inc. Announces Board Changes	23-08-24
Willow Biosciences Inc. Announces Collaboration with Biopharma Company to Develop New Sustainable Manufacturing Routes to Key Intermediates and Active Pharmaceutical Ingredients	23-08-21
Willow Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08
Willow Biosciences Inc. Provides Earnings Guidance for the Year 2023	23-08-08
Kalsec and Willow Biosciences Entry into A Follow-On Master Services Agreement to Develop Novel Enzyme for Production of an Advanced Beverage Ingredient	23-05-23
Willow Biosciences Inc. Announces Executive Changes	23-05-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Willow Biosciences Inc Canadian Securities Exchange

Equities

CA97111B1076

Other languages

Filters